Lifesci Capital Analyst Recommendations & Stock Picks

Name: Community Performance Rating
Item: Lifesci Capital
Rating: 2.5
Author: MarketBeat

This page lists the most recent publicly-reported stock recommendations and ratings issued by analysts at Lifesci Capital. These ratings and price targets were collected from public media reports and are believed to be accurate, but cannot be verified with 100% certainty. MarketBeat and its parent company are in no way affiliated with or endorsed by Lifesci Capital.

Brokerage Ranking: Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating MarketBeat
Average Return: 00.00% 12-Month ROI
Total Ratings: 39 Last 12 Months
Buy Ratings: 35 Last 12 Months
Sell Ratings: 0 Last 12 Months
Companies Covered: 33 Last 12 Months

Company	Current Price	Report Date	Analyst	Action	Price Target	Rating	Details
SLNO Soleno Therapeutics	$53.62 -5.5%	9/10/2025		Upgrade		Strong-Buy	View details for Lifesci Capital rating of Soleno Therapeutics (NASDAQ:SLNO) on 9/10/2025
GPCR Structure Therapeutics	$20.91 +0.1%	9/8/2025		Upgrade		Strong-Buy	View details for Lifesci Capital rating of Structure Therapeutics (NASDAQ:GPCR) on 9/8/2025
TRML Tourmaline Bio	$47.61 +0.0%	9/9/2025	Rami Katkhuda Subscribe to MarketBeat All Access for the analyst's recommendation accuracy rating	Downgrade	$48.00	Outperform ➝ Hold	View details for Lifesci Capital rating of Tourmaline Bio (NASDAQ:TRML) on 9/9/2025
PRAX Praxis Precision Medicines	$37.71 -4.3%	9/3/2025		Upgrade		Strong-Buy	View details for Lifesci Capital rating of Praxis Precision Medicines (NASDAQ:PRAX) on 9/3/2025
KALA KALA BIO	$18.62 +9.5%	9/3/2025		Upgrade		Strong-Buy	View details for Lifesci Capital rating of KALA BIO (NASDAQ:KALA) on 9/3/2025
CNTA Centessa Pharmaceuticals	$21.81 -3.8%	9/3/2025		Upgrade		Strong-Buy	View details for Lifesci Capital rating of Centessa Pharmaceuticals (NASDAQ:CNTA) on 9/3/2025
AVDL Avadel Pharmaceuticals	$15.40 -2.9%	9/3/2025		Upgrade		Strong-Buy	View details for Lifesci Capital rating of Avadel Pharmaceuticals (NASDAQ:AVDL) on 9/3/2025
AQST Aquestive Therapeutics	$5.05 +2.0%	9/3/2025		Upgrade		Strong-Buy	View details for Lifesci Capital rating of Aquestive Therapeutics (NASDAQ:AQST) on 9/3/2025
RVMD Revolution Medicines	$46.55 +0.7%	8/18/2025		Initiated Coverage	$80.00	Outperform	View details for Lifesci Capital rating of Revolution Medicines (NASDAQ:RVMD) on 8/18/2025
PVLA Palvella Therapeutics	$56.84 -2.8%	8/4/2025	Sam Slutsky Subscribe to MarketBeat All Access for the analyst's recommendation accuracy rating	Initiated Coverage	$90.00	Outperform	View details for Lifesci Capital rating of Palvella Therapeutics (NASDAQ:PVLA) on 8/4/2025
Get the Latest News and Ratings for Your Stocks Enter your email address below to receive the latest headlines and analysts' recommendations for your stocks with our free daily email newsletter.
ABVX Abivax	$84.01 -2.3%	7/23/2025	Sam Slutsky Subscribe to MarketBeat All Access for the analyst's recommendation accuracy rating	Boost Price Target	$45.00 ➝ $101.00	Outperform	View details for Lifesci Capital rating of Abivax (NASDAQ:ABVX) on 7/23/2025
RAPT Rapt Therapeutics	$16.22 +3.3%	7/22/2025		Upgrade	$31.00	Strong-Buy	View details for Lifesci Capital rating of Rapt Therapeutics (NASDAQ:RAPT) on 7/22/2025
CRBP Corbus Pharmaceuticals	$9.50	7/12/2025		Upgrade		Strong-Buy	View details for Lifesci Capital rating of Corbus Pharmaceuticals (NASDAQ:CRBP) on 7/12/2025
CATX Perspective Therapeutics	$3.48 +3.0%	7/12/2025	O. Mccammon Subscribe to MarketBeat All Access for the analyst's recommendation accuracy rating	Upgrade		Strong-Buy	View details for Lifesci Capital rating of Perspective Therapeutics (NYSE:CATX) on 7/12/2025
DBVT DBV Technologies	$9.87 -0.8%	6/26/2025	S. Slutsky Subscribe to MarketBeat All Access for the analyst's recommendation accuracy rating	Upgrade		Strong-Buy	View details for Lifesci Capital rating of DBV Technologies (NASDAQ:DBVT) on 6/26/2025
CBIO Crescent Biopharma	$12.49 -0.5%	6/18/2025	Charles Zhu Subscribe to MarketBeat All Access for the analyst's recommendation accuracy rating	Upgrade	$22.00	Strong-Buy	View details for Lifesci Capital rating of Crescent Biopharma (NASDAQ:CBIO) on 6/18/2025
TECX Tectonic Therapeutic	$17.72 -1.7%	6/5/2025	C. Jubinville Subscribe to MarketBeat All Access for the analyst's recommendation accuracy rating	Upgrade		Strong-Buy	View details for Lifesci Capital rating of Tectonic Therapeutic (NASDAQ:TECX) on 6/5/2025
TECX Tectonic Therapeutic	$17.72 -1.7%	6/6/2025		Initiated Coverage	$87.00	Outperform	View details for Lifesci Capital rating of Tectonic Therapeutic (NASDAQ:TECX) on 6/6/2025
SRRK Scholar Rock	$31.67 -0.5%	6/3/2025	D. Kennedy Subscribe to MarketBeat All Access for the analyst's recommendation accuracy rating	Upgrade		Strong-Buy	View details for Lifesci Capital rating of Scholar Rock (NASDAQ:SRRK) on 6/3/2025
GLUE Monte Rosa Therapeutics	$4.81 -1.6%	3/12/2025	O. Mccammon Subscribe to MarketBeat All Access for the analyst's recommendation accuracy rating	Initiated Coverage	$19.00	Outperform	View details for Lifesci Capital rating of Monte Rosa Therapeutics (NASDAQ:GLUE) on 3/12/2025
TARA Protara Therapeutics	$3.14 -1.9%	3/11/2025	C. Zhu Subscribe to MarketBeat All Access for the analyst's recommendation accuracy rating	Initiated Coverage	$22.00	Outperform	View details for Lifesci Capital rating of Protara Therapeutics (NASDAQ:TARA) on 3/11/2025
IMNM Immunome	$9.21 -4.9%	3/11/2025	C. Zhu Subscribe to MarketBeat All Access for the analyst's recommendation accuracy rating	Initiated Coverage	$20.00	Outperform	View details for Lifesci Capital rating of Immunome (NASDAQ:IMNM) on 3/11/2025
MOLN Molecular Partners	$3.68 -2.0%	3/11/2025	C. Zhu Subscribe to MarketBeat All Access for the analyst's recommendation accuracy rating	Initiated Coverage	$12.00	Outperform	View details for Lifesci Capital rating of Molecular Partners (NASDAQ:MOLN) on 3/11/2025
ZYME Zymeworks	$15.74 -3.6%	3/11/2025	C. Zhu Subscribe to MarketBeat All Access for the analyst's recommendation accuracy rating	Initiated Coverage	$30.00	Outperform	View details for Lifesci Capital rating of Zymeworks (NYSE:ZYME) on 3/11/2025
CATX Perspective Therapeutics	$3.48 +3.0%	3/6/2025	D. Kennedy Subscribe to MarketBeat All Access for the analyst's recommendation accuracy rating	Upgrade		Strong-Buy	View details for Lifesci Capital rating of Perspective Therapeutics (NYSE:CATX) on 3/6/2025
TRML Tourmaline Bio	$47.61 +0.0%	2/24/2025	Jimmy Shan Subscribe to MarketBeat All Access for the analyst's recommendation accuracy rating	Initiated Coverage	$58.00	Outperform	View details for Lifesci Capital rating of Tourmaline Bio (NASDAQ:TRML) on 2/24/2025
SLNO Soleno Therapeutics	$53.62 -5.5%	2/4/2025	M. Belghiti Subscribe to MarketBeat All Access for the analyst's recommendation accuracy rating	Upgrade		Strong-Buy	View details for Lifesci Capital rating of Soleno Therapeutics (NASDAQ:SLNO) on 2/4/2025
AURA Aura Biosciences	$6.18 -6.9%	1/31/2025	O. Mccammon Subscribe to MarketBeat All Access for the analyst's recommendation accuracy rating	Upgrade		Strong-Buy	View details for Lifesci Capital rating of Aura Biosciences (NASDAQ:AURA) on 1/31/2025
JANX Janux Therapeutics	$24.05 -4.3%	12/27/2024	O. Mccammon Subscribe to MarketBeat All Access for the analyst's recommendation accuracy rating	Upgrade		Strong-Buy	View details for Lifesci Capital rating of Janux Therapeutics (NASDAQ:JANX) on 12/27/2024
MREO Mereo BioPharma Group	$1.85 +1.6%	12/23/2024	C. Jubinville Subscribe to MarketBeat All Access for the analyst's recommendation accuracy rating	Upgrade		Strong-Buy	View details for Lifesci Capital rating of Mereo BioPharma Group (NASDAQ:MREO) on 12/23/2024
MREO Mereo BioPharma Group	$1.85 +1.6%	12/24/2024		Initiated Coverage	$10.00	Outperform	View details for Lifesci Capital rating of Mereo BioPharma Group (NASDAQ:MREO) on 12/24/2024
RPTX Repare Therapeutics	$1.76 -2.8%	12/13/2024	C. Zhu Subscribe to MarketBeat All Access for the analyst's recommendation accuracy rating	Reiterated Rating		Outperform ➝ Market Perform	View details for Lifesci Capital rating of Repare Therapeutics (NASDAQ:RPTX) on 12/13/2024
KURA Kura Oncology	$8.19 -7.1%	10/22/2024	C. Zhu Subscribe to MarketBeat All Access for the analyst's recommendation accuracy rating	Upgrade		Strong-Buy	View details for Lifesci Capital rating of Kura Oncology (NASDAQ:KURA) on 10/22/2024
OKUR OnKure Therapeutics	$2.45 +0.4%	10/10/2024	S. Slutsky Subscribe to MarketBeat All Access for the analyst's recommendation accuracy rating	Upgrade		Strong-Buy	View details for Lifesci Capital rating of OnKure Therapeutics (NASDAQ:OKUR) on 10/10/2024
LQDA Liquidia Technologies	$25.99 -3.7%	10/2/2024	C. Jubinville Subscribe to MarketBeat All Access for the analyst's recommendation accuracy rating	Upgrade		Strong-Buy	View details for Lifesci Capital rating of Liquidia Technologies (NASDAQ:LQDA) on 10/2/2024
LQDA Liquidia Technologies	$25.99 -3.7%	10/3/2024		Initiated Coverage	$30.00	Outperform	View details for Lifesci Capital rating of Liquidia Technologies (NASDAQ:LQDA) on 10/3/2024
ORKA Oruka Therapeutics	$15.40 -4.6%	9/16/2024	S. Slutsky Subscribe to MarketBeat All Access for the analyst's recommendation accuracy rating	Initiated Coverage	$41.00	Outperform	View details for Lifesci Capital rating of Oruka Therapeutics (NASDAQ:ORKA) on 9/16/2024
AURA Aura Biosciences	$6.18 -6.9%	9/9/2024	A. Dhankher Subscribe to MarketBeat All Access for the analyst's recommendation accuracy rating	Upgrade		Strong-Buy	View details for Lifesci Capital rating of Aura Biosciences (NASDAQ:AURA) on 9/9/2024
CELC Celcuity	$54.91 -4.4%	8/26/2024	O. Mccammon Subscribe to MarketBeat All Access for the analyst's recommendation accuracy rating	Initiated Coverage	$27.00	Outperform	View details for Lifesci Capital rating of Celcuity (NASDAQ:CELC) on 8/26/2024
CRBP Corbus Pharmaceuticals	$9.50	8/21/2024	M. Belghiti Subscribe to MarketBeat All Access for the analyst's recommendation accuracy rating	Upgrade		Strong-Buy	View details for Lifesci Capital rating of Corbus Pharmaceuticals (NASDAQ:CRBP) on 8/21/2024

ALXO ALX Oncology	$1.06 -10.2%	7/31/2024	S. Slutsky Subscribe to MarketBeat All Access for the analyst's recommendation accuracy rating	Downgrade		Strong-Buy ➝ Hold	View details for Lifesci Capital rating of ALX Oncology (NASDAQ:ALXO) on 7/31/2024
RPTX Repare Therapeutics	$1.76 -2.8%	7/29/2024	C. Zhu Subscribe to MarketBeat All Access for the analyst's recommendation accuracy rating	Upgrade		Strong-Buy	View details for Lifesci Capital rating of Repare Therapeutics (NASDAQ:RPTX) on 7/29/2024
NUVL Nuvalent	$80.47 -2.1%	7/29/2024	C. Zhu Subscribe to MarketBeat All Access for the analyst's recommendation accuracy rating	Upgrade		Strong-Buy	View details for Lifesci Capital rating of Nuvalent (NASDAQ:NUVL) on 7/29/2024
MRUS Merus	$69.58 -0.3%	7/29/2024	C. Zhu Subscribe to MarketBeat All Access for the analyst's recommendation accuracy rating	Upgrade		Strong-Buy	View details for Lifesci Capital rating of Merus (NASDAQ:MRUS) on 7/29/2024
MRSN Mersana Therapeutics	$7.14 -4.4%	7/29/2024	C. Zhu Subscribe to MarketBeat All Access for the analyst's recommendation accuracy rating	Upgrade		Strong-Buy	View details for Lifesci Capital rating of Mersana Therapeutics (NASDAQ:MRSN) on 7/29/2024
IDYA IDEAYA Biosciences	$24.61 -1.3%	7/29/2024	C. Zhu Subscribe to MarketBeat All Access for the analyst's recommendation accuracy rating	Upgrade		Strong-Buy	View details for Lifesci Capital rating of IDEAYA Biosciences (NASDAQ:IDYA) on 7/29/2024
DNTH Dianthus Therapeutics	$37.16 -1.8%	6/11/2024	R. Katkhuda Subscribe to MarketBeat All Access for the analyst's recommendation accuracy rating	Upgrade		Strong-Buy	View details for Lifesci Capital rating of Dianthus Therapeutics (NASDAQ:DNTH) on 6/11/2024
CALT Calliditas Therapeutics AB (publ)	$40.00	5/28/2024	R. Katkhuda Subscribe to MarketBeat All Access for the analyst's recommendation accuracy rating	Downgrade		Strong-Buy ➝ Hold	View details for Lifesci Capital rating of Calliditas Therapeutics AB (publ) (NASDAQ:CALT) on 5/28/2024
CATX Perspective Therapeutics	$3.48 +3.0%	5/6/2024	A. Dhankher Subscribe to MarketBeat All Access for the analyst's recommendation accuracy rating	Reiterated Rating		Outperform	View details for Lifesci Capital rating of Perspective Therapeutics (NYSE:CATX) on 5/6/2024
MLYS Mineralys Therapeutics	$37.10 -0.2%	3/26/2024	R. Katkhuda Subscribe to MarketBeat All Access for the analyst's recommendation accuracy rating	Reiterated Rating		Outperform	View details for Lifesci Capital rating of Mineralys Therapeutics (NASDAQ:MLYS) on 3/26/2024
GPCR Structure Therapeutics	$20.91 +0.1%	2/27/2024	M. Belghiti Subscribe to MarketBeat All Access for the analyst's recommendation accuracy rating	Reiterated Rating		Outperform	View details for Lifesci Capital rating of Structure Therapeutics (NASDAQ:GPCR) on 2/27/2024
VTYX Ventyx Biosciences	$2.30 -3.4%	2/28/2024	S. Slutsky Subscribe to MarketBeat All Access for the analyst's recommendation accuracy rating	Upgrade		Market Perform ➝ Outperform	View details for Lifesci Capital rating of Ventyx Biosciences (NASDAQ:VTYX) on 2/28/2024
LRMR Larimar Therapeutics	$3.93 -5.8%	2/20/2024	C. Jubinville Subscribe to MarketBeat All Access for the analyst's recommendation accuracy rating	Reiterated Rating		Outperform	View details for Lifesci Capital rating of Larimar Therapeutics (NASDAQ:LRMR) on 2/20/2024
INBX Inhibrx Biosciences	$27.52 -3.3%	1/23/2024	S. Slutsky Subscribe to MarketBeat All Access for the analyst's recommendation accuracy rating	Downgrade		Outperform ➝ Market Perform	View details for Lifesci Capital rating of Inhibrx Biosciences (NASDAQ:INBX) on 1/23/2024
IVA Inventiva	$5.61 -2.8%	1/5/2024	R. Katkhuda Subscribe to MarketBeat All Access for the analyst's recommendation accuracy rating	Reiterated Rating		Outperform	View details for Lifesci Capital rating of Inventiva (NASDAQ:IVA) on 1/5/2024
TARS Tarsus Pharmaceuticals	$49.36 -4.8%	12/26/2023	C. Jubinville Subscribe to MarketBeat All Access for the analyst's recommendation accuracy rating	Reiterated Rating		Outperform	View details for Lifesci Capital rating of Tarsus Pharmaceuticals (NASDAQ:TARS) on 12/26/2023
RCKT Rocket Pharmaceuticals	$3.16 -3.7%	12/26/2023	C. Jubinville Subscribe to MarketBeat All Access for the analyst's recommendation accuracy rating	Reiterated Rating		Outperform	View details for Lifesci Capital rating of Rocket Pharmaceuticals (NASDAQ:RCKT) on 12/26/2023
SYRE Spyre Therapeutics	$15.65 -3.4%	12/4/2023	S. Slutsky Subscribe to MarketBeat All Access for the analyst's recommendation accuracy rating	Reiterated Rating		Outperform	View details for Lifesci Capital rating of Spyre Therapeutics (NASDAQ:SYRE) on 12/4/2023
TCRX TScan Therapeutics	$1.76 -4.9%	11/27/2023	S. Slutsky Subscribe to MarketBeat All Access for the analyst's recommendation accuracy rating	Reiterated Rating		Outperform	View details for Lifesci Capital rating of TScan Therapeutics (NASDAQ:TCRX) on 11/27/2023
VTYX Ventyx Biosciences	$2.30 -3.4%	11/7/2023	S. Slutsky Subscribe to MarketBeat All Access for the analyst's recommendation accuracy rating	Downgrade		Outperform ➝ Market Perform	View details for Lifesci Capital rating of Ventyx Biosciences (NASDAQ:VTYX) on 11/7/2023
INBX Inhibrx Biosciences	$27.52 -3.3%	8/8/2023	S. Slutsky Subscribe to MarketBeat All Access for the analyst's recommendation accuracy rating	Reiterated Rating		Outperform	View details for Lifesci Capital rating of Inhibrx Biosciences (NASDAQ:INBX) on 8/8/2023
TNYA Tenaya Therapeutics	$1.20 -6.3%	8/8/2023	P. Dolezal Subscribe to MarketBeat All Access for the analyst's recommendation accuracy rating	Reiterated Rating		Outperform	View details for Lifesci Capital rating of Tenaya Therapeutics (NASDAQ:TNYA) on 8/8/2023
PYXS Pyxis Oncology	$1.82 -2.2%	4/26/2023	S. Slutsky Subscribe to MarketBeat All Access for the analyst's recommendation accuracy rating	Reiterated Rating		Outperform	View details for Lifesci Capital rating of Pyxis Oncology (NASDAQ:PYXS) on 4/26/2023
OLMA Olema Pharmaceuticals	$7.77 -2.9%	4/26/2023	S. Slutsky Subscribe to MarketBeat All Access for the analyst's recommendation accuracy rating	Reiterated Rating		Outperform	View details for Lifesci Capital rating of Olema Pharmaceuticals (NASDAQ:OLMA) on 4/26/2023
INBX Inhibrx Biosciences	$27.52 -3.3%	4/26/2023	P. Dolezal Subscribe to MarketBeat All Access for the analyst's recommendation accuracy rating	Reiterated Rating		Outperform	View details for Lifesci Capital rating of Inhibrx Biosciences (NASDAQ:INBX) on 4/26/2023
AVDL Avadel Pharmaceuticals	$15.40 -2.9%	4/26/2023	P. Dolezal Subscribe to MarketBeat All Access for the analyst's recommendation accuracy rating	Reiterated Rating		Outperform	View details for Lifesci Capital rating of Avadel Pharmaceuticals (NASDAQ:AVDL) on 4/26/2023
ALXO ALX Oncology	$1.06 -10.2%	4/26/2023	S. Slutsky Subscribe to MarketBeat All Access for the analyst's recommendation accuracy rating	Reiterated Rating		Outperform	View details for Lifesci Capital rating of ALX Oncology (NASDAQ:ALXO) on 4/26/2023
IRON Disc Medicine	$59.82 -0.8%	4/24/2023	R. Katkhuda Subscribe to MarketBeat All Access for the analyst's recommendation accuracy rating	Reiterated Rating		Outperform	View details for Lifesci Capital rating of Disc Medicine (NASDAQ:IRON) on 4/24/2023
AKRO Akero Therapeutics	$43.46 -3.3%	4/11/2023	P. Dolezal Subscribe to MarketBeat All Access for the analyst's recommendation accuracy rating	Reiterated Rating		Outperform	View details for Lifesci Capital rating of Akero Therapeutics (NASDAQ:AKRO) on 4/11/2023
IFRX InflaRx	$1.26 -14.3%	4/5/2023		Upgrade		Market Perform ➝ Outperform	View details for Lifesci Capital rating of InflaRx (NASDAQ:IFRX) on 4/5/2023
CRNX Crinetics Pharmaceuticals	$34.00 +0.8%	3/27/2023	C. Jubinville Subscribe to MarketBeat All Access for the analyst's recommendation accuracy rating	Reiterated Rating		Outperform	View details for Lifesci Capital rating of Crinetics Pharmaceuticals (NASDAQ:CRNX) on 3/27/2023
OBIO Orchestra BioMed	$2.57 -1.9%	3/8/2023	R. Rakhit Subscribe to MarketBeat All Access for the analyst's recommendation accuracy rating	Reiterated Rating		Outperform	View details for Lifesci Capital rating of Orchestra BioMed (NASDAQ:OBIO) on 3/8/2023
ELVN Enliven Therapeutics	$19.96 +0.2%	3/7/2023	S. Slutsky Subscribe to MarketBeat All Access for the analyst's recommendation accuracy rating	Reiterated Rating		Outperform	View details for Lifesci Capital rating of Enliven Therapeutics (NASDAQ:ELVN) on 3/7/2023
MLTX MoonLake Immunotherapeutics	$52.62 -3.1%	12/21/2022	R. Katkhuda Subscribe to MarketBeat All Access for the analyst's recommendation accuracy rating	Reiterated Rating		Outperform	View details for Lifesci Capital rating of MoonLake Immunotherapeutics (NASDAQ:MLTX) on 12/21/2022
PYXS Pyxis Oncology	$1.82 -2.2%	12/1/2022	A. Evertts Subscribe to MarketBeat All Access for the analyst's recommendation accuracy rating	Reiterated Rating		Outperform	View details for Lifesci Capital rating of Pyxis Oncology (NASDAQ:PYXS) on 12/1/2022
ATXS Astria Therapeutics	$7.43 -5.2%	11/28/2022	S. Slutsky Subscribe to MarketBeat All Access for the analyst's recommendation accuracy rating	Reiterated Rating		Outperform	View details for Lifesci Capital rating of Astria Therapeutics (NASDAQ:ATXS) on 11/28/2022
ALXO ALX Oncology	$1.06 -10.2%	11/8/2022	A. Evertts Subscribe to MarketBeat All Access for the analyst's recommendation accuracy rating	Reiterated Rating		Outperform	View details for Lifesci Capital rating of ALX Oncology (NASDAQ:ALXO) on 11/8/2022
LRMR Larimar Therapeutics	$3.93 -5.8%	8/12/2022	P. Dolezal Subscribe to MarketBeat All Access for the analyst's recommendation accuracy rating	Upgrade		Market Perform ➝ Outperform	View details for Lifesci Capital rating of Larimar Therapeutics (NASDAQ:LRMR) on 8/12/2022
TNYA Tenaya Therapeutics	$1.20 -6.3%	6/16/2022	P. Dolezal Subscribe to MarketBeat All Access for the analyst's recommendation accuracy rating	Reiterated Rating		Outperform	View details for Lifesci Capital rating of Tenaya Therapeutics (NASDAQ:TNYA) on 6/16/2022
VERA Vera Therapeutics	$23.77 -3.1%	3/28/2022	R. Katkhuda Subscribe to MarketBeat All Access for the analyst's recommendation accuracy rating	Reiterated Rating		Outperform	View details for Lifesci Capital rating of Vera Therapeutics (NASDAQ:VERA) on 3/28/2022
ELDN Eledon Pharmaceuticals	$2.42 -4.7%	3/25/2022	R. Katkhuda Subscribe to MarketBeat All Access for the analyst's recommendation accuracy rating	Reiterated Rating		Outperform	View details for Lifesci Capital rating of Eledon Pharmaceuticals (NASDAQ:ELDN) on 3/25/2022
LRMR Larimar Therapeutics	$3.93 -5.8%	2/16/2022	Patrick Dolezal Subscribe to MarketBeat All Access for the analyst's recommendation accuracy rating	Downgrade	$3.00	Outperform ➝ Market Perform	View details for Lifesci Capital rating of Larimar Therapeutics (NASDAQ:LRMR) on 2/16/2022
NNOX Nano-X Imaging	$3.90 -1.8%	11/17/2021	R. Rakhit Subscribe to MarketBeat All Access for the analyst's recommendation accuracy rating	Downgrade		Outperform ➝ Market Perform	View details for Lifesci Capital rating of Nano-X Imaging (NASDAQ:NNOX) on 11/17/2021
VTYX Ventyx Biosciences	$2.30 -3.4%	11/15/2021	S. Slutsky Subscribe to MarketBeat All Access for the analyst's recommendation accuracy rating	Reiterated Rating		Outperform	View details for Lifesci Capital rating of Ventyx Biosciences (NASDAQ:VTYX) on 11/15/2021
ALXO ALX Oncology	$1.06 -10.2%	11/4/2021	A. Evertts Subscribe to MarketBeat All Access for the analyst's recommendation accuracy rating	Reiterated Rating		Outperform	View details for Lifesci Capital rating of ALX Oncology (NASDAQ:ALXO) on 11/4/2021
PYXS Pyxis Oncology	$1.82 -2.2%	11/2/2021	A. Evertts Subscribe to MarketBeat All Access for the analyst's recommendation accuracy rating	Reiterated Rating		Outperform	View details for Lifesci Capital rating of Pyxis Oncology (NASDAQ:PYXS) on 11/2/2021
RCKT Rocket Pharmaceuticals	$3.16 -3.7%	10/24/2021	P. Dolezal Subscribe to MarketBeat All Access for the analyst's recommendation accuracy rating	Reiterated Rating		Outperform	View details for Lifesci Capital rating of Rocket Pharmaceuticals (NASDAQ:RCKT) on 10/24/2021
DRIO DarioHealth	$7.11 +0.3%	8/26/2021	R. Rakhit Subscribe to MarketBeat All Access for the analyst's recommendation accuracy rating	Reiterated Rating		Outperform	View details for Lifesci Capital rating of DarioHealth (NASDAQ:DRIO) on 8/26/2021
VRDN Viridian Therapeutics	$18.87 -4.0%	8/24/2021	R. Katkhuda Subscribe to MarketBeat All Access for the analyst's recommendation accuracy rating	Reiterated Rating		Outperform	View details for Lifesci Capital rating of Viridian Therapeutics (NASDAQ:VRDN) on 8/24/2021
LRMR Larimar Therapeutics	$3.93 -5.8%	8/4/2021	P. Dolezal Subscribe to MarketBeat All Access for the analyst's recommendation accuracy rating	Reiterated Rating		Outperform	View details for Lifesci Capital rating of Larimar Therapeutics (NASDAQ:LRMR) on 8/4/2021

OLMA Olema Pharmaceuticals	$7.77 -2.9%	6/21/2021	A. Evertts Subscribe to MarketBeat All Access for the analyst's recommendation accuracy rating	Reiterated Rating		Outperform	View details for Lifesci Capital rating of Olema Pharmaceuticals (NASDAQ:OLMA) on 6/21/2021
NNOX Nano-X Imaging	$3.90 -1.8%	6/3/2021	R. Rakhit Subscribe to MarketBeat All Access for the analyst's recommendation accuracy rating	Reiterated Rating		Outperform	View details for Lifesci Capital rating of Nano-X Imaging (NASDAQ:NNOX) on 6/3/2021
VECT VectivBio	$16.85	5/4/2021	P. Dolezal Subscribe to MarketBeat All Access for the analyst's recommendation accuracy rating	Reiterated Rating		Outperform	View details for Lifesci Capital rating of VectivBio (NASDAQ:VECT) on 5/4/2021
ADVM Adverum Biotechnologies	$3.02 -3.8%	4/29/2021	P. Dolezal Subscribe to MarketBeat All Access for the analyst's recommendation accuracy rating	Downgrade		Outperform ➝ Market Perform	View details for Lifesci Capital rating of Adverum Biotechnologies (NASDAQ:ADVM) on 4/29/2021
ELDN Eledon Pharmaceuticals	$2.42 -4.7%	3/18/2021	R. Katkhuda Subscribe to MarketBeat All Access for the analyst's recommendation accuracy rating	Reiterated Rating		Outperform	View details for Lifesci Capital rating of Eledon Pharmaceuticals (NASDAQ:ELDN) on 3/18/2021
COGT Cogent Biosciences	$12.66 -1.2%	1/4/2021	S. Slutsky Subscribe to MarketBeat All Access for the analyst's recommendation accuracy rating	Reiterated Rating		Outperform	View details for Lifesci Capital rating of Cogent Biosciences (NASDAQ:COGT) on 1/4/2021
CLDX Celldex Therapeutics	$24.45 -3.0%	11/17/2020	S. Slutsky Subscribe to MarketBeat All Access for the analyst's recommendation accuracy rating	Reiterated Rating		Outperform	View details for Lifesci Capital rating of Celldex Therapeutics (NASDAQ:CLDX) on 11/17/2020
TARS Tarsus Pharmaceuticals	$49.36 -4.8%	11/10/2020	P. Dolezal Subscribe to MarketBeat All Access for the analyst's recommendation accuracy rating	Reiterated Rating		Outperform	View details for Lifesci Capital rating of Tarsus Pharmaceuticals (NASDAQ:TARS) on 11/10/2020
AVDL Avadel Pharmaceuticals	$15.40 -2.9%	11/9/2020	D. Sherman Subscribe to MarketBeat All Access for the analyst's recommendation accuracy rating	Reiterated Rating		Outperform	View details for Lifesci Capital rating of Avadel Pharmaceuticals (NASDAQ:AVDL) on 11/9/2020
CBIO Crescent Biopharma	$12.49 -0.5%	11/5/2020	S. Slutsky Subscribe to MarketBeat All Access for the analyst's recommendation accuracy rating	Reiterated Rating		Outperform	View details for Lifesci Capital rating of Crescent Biopharma (NASDAQ:CBIO) on 11/5/2020
ADVM Adverum Biotechnologies	$3.02 -3.8%	11/5/2020	P. Dolezal Subscribe to MarketBeat All Access for the analyst's recommendation accuracy rating	Reiterated Rating		Outperform	View details for Lifesci Capital rating of Adverum Biotechnologies (NASDAQ:ADVM) on 11/5/2020
IFRX InflaRx	$1.26 -14.3%	10/30/2020	S. Slutsky Subscribe to MarketBeat All Access for the analyst's recommendation accuracy rating	Reiterated Rating		Market Perform	View details for Lifesci Capital rating of InflaRx (NASDAQ:IFRX) on 10/30/2020
MEIP MEI Pharma	$3.19 +14.7%	10/21/2020	A. Evertts Subscribe to MarketBeat All Access for the analyst's recommendation accuracy rating	Reiterated Rating		Outperform	View details for Lifesci Capital rating of MEI Pharma (NASDAQ:MEIP) on 10/21/2020
RCKT Rocket Pharmaceuticals	$3.16 -3.7%	10/16/2020	P. Dolezal Subscribe to MarketBeat All Access for the analyst's recommendation accuracy rating	Reiterated Rating		Outperform	View details for Lifesci Capital rating of Rocket Pharmaceuticals (NASDAQ:RCKT) on 10/16/2020
INBX Inhibrx Biosciences	$27.52 -3.3%	10/15/2020	A. Evertts Subscribe to MarketBeat All Access for the analyst's recommendation accuracy rating	Reiterated Rating		Outperform	View details for Lifesci Capital rating of Inhibrx Biosciences (NASDAQ:INBX) on 10/15/2020
IMVT Immunovant	$16.16 -3.8%	10/6/2020	S. Slutsky Subscribe to MarketBeat All Access for the analyst's recommendation accuracy rating	Reiterated Rating		Outperform	View details for Lifesci Capital rating of Immunovant (NASDAQ:IMVT) on 10/6/2020
ALXO ALX Oncology	$1.06 -10.2%	9/30/2020	A. Evertts Subscribe to MarketBeat All Access for the analyst's recommendation accuracy rating	Reiterated Rating		Outperform	View details for Lifesci Capital rating of ALX Oncology (NASDAQ:ALXO) on 9/30/2020
CRTX Cortexyme	$1.60 +1.3%	9/24/2020	D. Sherman Subscribe to MarketBeat All Access for the analyst's recommendation accuracy rating	Reiterated Rating		Outperform	View details for Lifesci Capital rating of Cortexyme (NASDAQ:CRTX) on 9/24/2020

MarketBeat Community Rating for Lifesci Capital

Community Ranking:		2.5 out of 5 ( 2.5 of 5 stars)
Outperform Votes:		35,094 (Vote Outperform)
Underperform Votes:		36,157 (Vote Underperform)
Total Votes:		71,251

MarketBeat's community ratings are surveys of what our community members think about Lifesci Capital and other research firms. Vote "Outperform" if you believe Lifesci Capital's recommendations will outperform the S&P 500 over the long term. Vote "Underperform" if you believe Lifesci Capital's recommendations will underperform the S&P 500 over the long term. You may vote once every thirty days.

Stock Forecasts and Research Tools

Today's Ratings

Top-Rated Stocks

More Ratings Tools

Price Forecasts for Popular Stocks

Get 30 Days of MarketBeat All Access for Free

Start Your 30-Day Trial

In-depth profiles and analysis for 20,000 public companies.
Real-time analyst ratings, insider transactions, earnings data, and more.
Our daily ratings and market update email newsletter.

Sign In
Create Account

Your Email Address:

Your Password:

Forgot your password?

Your Email Address:

Choose a Password:

By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

Lifesci Capital Analyst Recommendations & Stock Picks

MarketBeat Community Rating for Lifesci Capital

Stock Forecasts and Research Tools

Best-in-Class Portfolio Monitoring

Stock Ideas and Recommendations

Advanced Stock Screeners and Research Tools

About MarketBeat

MarketBeat Products

Popular Tools

Financial Calendars

Terms & Info

Lifesci Capital Analyst Recommendations & Stock Picks

MarketBeat Community Rating for Lifesci Capital

Stock Forecasts and Research Tools

MarketBeat All Access Features

Best-in-Class Portfolio Monitoring

Stock Ideas and Recommendations

Advanced Stock Screeners and Research Tools